Meet us at ESMO, booth \#8005 to discuss how ICON integrates expertise, flexible partnership and delivery models, proven technology and global infrastructure to reduce risk, improve decision making and advance programs f...

Building an AI-enabled SaMD? Don't leave regulatory feedback until the end. Early FDA engagement can help align expectations, strengthen your evidence strategy and keep development on track. Read our latest blog for tip...

Antimicrobial-resistant Neisseria gonorrhoeae represents one of the most pressing challenges in infectious disease, with the WHO targeting a 90% incidence reduction by 2030. Resistance has emerged against nearly every cl...

Europe’s oncology biosimilar market is entering its next phase. Scientific methods are advancing, regulatory expectations are evolving and more biologics are approaching loss of protection. Yet securing regulatory appro...

Heading to #ObesityWeek? Connect with ICON experts at booth \#212 to explore how our cross-functional obesity expertise and integrated scientific and operational support can help navigate the complexities of obesity deve...

Could streamlined regulatory pathways reduce the need for comparative efficacy studies in some biosimilar programmes? In this BioProcess International article, authors Kimberly Salgado & Radboud van Trigt discuss how re...

As oncology programs become increasingly complex, medical imaging plays a critical role in development success. ICON Medical Imaging combines scientific leadership, strategic insight and integrated solutions to support s...

Connect with ICON’s hepatology experts at AASLD, booth \#1861, to explore how we can support your liver disease trials, from smarter site selection powered by AI and expert insight to imaging, biomarkers and endpoint str...

Rare disease studies demand flexibility. Digital solutions and decentralised models can help reduce patient burden, improve access and support participation. Meet the ICON team at #WorldOrphanEU, booth \#313, to discuss ...

Our colleagues in Peru came together to recognise Breast Cancer Awareness Month and help raise awareness of the importance of prevention and early detection. Wearing pink and the pink ribbon, the team took part in a wel...

It was a fantastic few days in Orlando, connecting with colleagues from across the clinical research community, exchanging ideas and hearing perspectives from both sites and sponsors on how we can work together to improv...

ICON are proud to be the platinum sponsor of this year's TOPRA Symposium, which brings together regulatory professionals from across industry, regulatory bodies and academia to exchange perspectives on the future of heal...